Aug 2026· Nature Communications· Vol 17· 1 citation· 95 references
Medicine
TL;DR
Deep long-read RNA sequencing and proteomics in induced pluripotent stem cell-derived cortical neurons is integrated to generate a high-resolution proteogenomic atlas of human neuron development, uncovering thousands of novel isoforms and revealing dynamic splicing changes in autism risk genes.
Abstract
RNA splicing shapes neuronal identity and disease risk, yet current maps lack the developmental resolution and depth to resolve this complexity. Here, we integrate deep long-read RNA sequencing and proteomics in induced pluripotent stem cell-derived cortical neurons to generate a high-resolution proteogenomic atlas of human neuron development. We identify 182,371 mRNA isoforms (over half previously unknown) and provide direct peptide evidence for the translation of hundreds of novel protein-coding sequences. Population genetics demonstrates that variants affecting novel exons and splice sites are under negative selection, underscoring the potential significance of these isoforms. During neuronal maturation, we observe that autism risk genes undergo dynamic isoform switching, including microexon inclusion and intron retention, that remodel key protein domains and regulatory regions. Furthermore, we uncover widespread, long-range coordination between alternative transcript processing events, including transcription start sites, exon splicing, and polyadenylation. Finally, our atlas enables variant reinterpretation in autism, highlighting the value of an isoform-centric view for interpreting pathogenic variation in neurodevelopment. Alternative splicing expands neuronal diversity, but many brain RNA isoforms remain uncharacterized. Here, the authors generate a high‑resolution proteogenomic atlas of human neuron development, uncovering thousands of novel isoforms and revealing dynamic splicing changes in autism risk genes.
The first single cell long-read sequencing dataset of fetal human retina can help elucidate the role of alternative splicing in retinal development and guide the design of transcript-specific gene therapies for retinal regeneration.
Analysis of RNA-sequencing data from nine iPSC-derived cell types and dozens of human transcriptomic conserved deletions suggests that evolution of HMMR splicing in humans increased plasticity in cell division, potentially leading to tradeoffs between advantageous effects on brain development and deleterious effects on...
Alexander L. Starr, A. Villalba, Jenna Rever et al.· bioRxiv· 0 citations
The most comprehensive, tissue-resolved alternative splicing dataset in Caenorhabditis elegans to date is presented, spanning three major tissue types from early embryogenesis to adulthood, and broad developmental and tissue-regulated alternative splicing trends are uncovered and putative RNA-binding proteins are ident...
Bina Koterniak, Ernest Liang, Michael Zoberman et al.· bioRxiv· 0 citations
SpliceImpactR is introduced, an open-source tool that systematically identifies RNA isoform switches—including alternative first and last exons, exon skipping, intron retention, hybrid exons, and splice site variation—across the human transcriptome, and predicts their impact on encoded proteins.
Zachary Peters Wakefield, Ana Fiszbein· bioRxiv· 2 citations
A scalable, cell-type-resolved in vivo CRISPR interference (CRISPRi) platform enabling systematic gene function profiling in the mouse brain is developed and the CRISPRinvivo data portal is established as a community resource for in vivo screening.
Risheng Lin, Ze-Ting Ke, Jian-Hui Wang et al.· Neuron· 0 citations
This genome and transcriptome-integrated annotation establishes a high-resolution framework for studying neuronal gene organization in C. borealis, supporting future investigations in crustacean neurogenomics, comparative genomics, and the evolution of nervous system complexity.
Murugesan Raju, Adam J. Northcutt, David J. Schulz· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.